Biotech Drug Pricing and Value-Based Care

Exploring the pricing of drugs in the biotech industry based on dosages and outcomes, alongside a discussion on the movement towards value-based pricing in the drug and pharma sector. Reflecting on drug innovations and the challenges of balancing breakthroughs for diseases with high costs, while exploring the potential of technology like AI in optimizing medication doses and precision medicine.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app